Children and adolescents with Friedreich’s ataxia (FA) who have an enlarged heart were found to have a high prevalence…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Increased sodium levels were found in regions of the brain commonly affected by Friedreich ataxia (FA) — the cerebellum…
Compounds that blocked the activity of histone deacetylases — enzymes that suppress gene activity — increased the activity of the…
Reata Pharmaceuticals has completed a rolling submission of a new drug application (NDA) seeking approval in the U.S. for…
Reduced thickness of the peripapillary retinal nerve fiber layer (RNFL) in the eye’s retina is associated with worse disease severity…
People who have interruptions in a specific part of their GAA repeats in the FXN gene experience the onset of…
In addition to three recruiting clinical studies that were announced in June, an additional trial is seeking participants with…
Truncated forms of frataxin, the protein that is lost in people with Friedreich’s ataxia (FA), were found predominantly in…
After nearly one year of its use, omaveloxolone (RTA 408) significantly improved neurological function across several clinical…
The natural antioxidant epicatechin significantly improves heart structure and function in young people with…